Welcome to Chinese Journal of Clinical Pharmacology and Therapeutics,Today is Chinese

Chinese Journal of Clinical Pharmacology and Therapeutics ›› 2011, Vol. 16 ›› Issue (8): 862-866.

Previous Articles     Next Articles

Effect of twelve-degree of polymerization heparin oigosaccharide on proliferation in vascular smooth muscle cells

LI Wei1, CHEN Li-ping2, LI Li1, XU Guang-lin3, HE Shu-ying1   

  1. 1Department of Life Science and Technology, China Pharmaceutical University, Nanjing 210009, Jiangsu, China;
    2Zhejiang Jinhua CONBA Bio-pharm Co.,Ltd, Jinhua 321016, Zhejiang, China;
    3College of Life Science, Nanjing Normal University, Nanjing 210097, Jiangsu, China
  • Received:2011-05-09 Revised:2011-07-05 Online:2011-08-26 Published:2011-09-07

Abstract: AIM: To investigate the effects of 12-degree of polymerization heparin oigosaccharid (dp12) on proliferation in vascular smooth muscle cells (VSMCs) and to analyze their activated signal transduction pathways.METHODS: In this study, the proliferation of VSMCs of bovine thoracic aorta was induced by 10% NCS and the effects of dp12 on VMSCs proliferation followed upon different concentrations. MTT assay was evaluated to indicate the proliferation of VSMCs; flow cytometry was used to detect the cell cycle; the ERK mRNA and phosphor protein of ERK were detected by reverse transcription polymerase chain reaction (RT-PCR) and western-blotting respectively.RESULTS: MTT assay showed the inhibitory effects of dp12 on VSMCs induced by 10% NCS; flow cytometry revealed that the inhibited proliferation was a result of the interference of VSMCs entering S phase from G1 phase; western-blotting and RT-PCR profiles proved that dp12 inhibited the transcription and phosphorylation of ERK1/2.CONCLUSION: 12-Degree of polymerization heparin oigosaccharid inhibits the VSMCs entering S phase from G1 phase, it also inhibits the transcripttion and phosphorylation of ERK1/2, which might be the putative anti-proliferation mechanism of VSMCs.

Key words: Heparin oigosaccharide, Proliferation, Vascular smooth muscle cells, ERK1/2

CLC Number: